Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac

Elisabeth M Lodder1, Brendon P Scicluna, Annalisa Milano

  • 1Heart Failure Research Center, Department of Experimental Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Plos Genetics
|December 14, 2012
PubMed

Insights

Scientists identified Tnni3k as a gene influencing heart rhythm. This discovery sheds light on the genetic basis of atrio-ventricular conduction and may help understand sudden cardiac death risks.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Electrophysiology

Background:

  • Atrio-ventricular conduction disease, marked by prolonged PR interval on ECG, is linked to Mendelian rhythm disorders and sudden cardiac death.
  • PR interval prolongation predicts atrial fibrillation, a common arrhythmia, yet its genetic regulators are poorly understood.
  • Previous studies mapped a quantitative trait locus (QTL) for PR interval duration in mice.

Purpose of the Study:

  • To identify the specific gene responsible for the PR interval duration QTL in mice.
  • To investigate the role of Tnni3k in regulating atrio-ventricular conduction.

Main Methods:

  • Genome-wide transcriptional profiling of myocardial tissue from 109 F2 mice.
  • Mapping of expression QTLs (eQTLs) and correlation analysis with PR interval duration.
  • Genotype analysis and PR interval measurements in various inbred mouse strains, including genetically modified mice.

Main Results:

  • Tnni3k was identified as the sole eQTL within the PR interval QTL region, exhibiting cardiac-specific expression and correlating with PR duration.
  • Multiple Tnni3k haplotypes exist across mouse strains, with higher mRNA levels associated with longer PR intervals.
  • Overexpression of Tnni3k in mice led to a prolonged PR interval.

Conclusions:

  • Tnni3k plays a significant role in controlling the electrocardiographic PR interval.
  • This finding provides the first evidence linking Tnni3k to atrio-ventricular conduction regulation.
  • Tnni3k is a potential target for understanding and managing cardiac conduction disorders.